Qyuns Therapeutics Co., Ltd. 江蘇荃信生物醫藥股份有限公司

Pay for financial year ended 2024-12-31

Source: Annual report

Note: while most data are extracted from annual reports, some data in these tables may have been taken from supplemental filings made in response to complaints to SEHK by our volunteer editors. Please report any errors.

Name Last
position
Fees Salary &
benefits
Bonus Retire Share-
based
Total

CNY '000

Supervisors

1 Ding, Chao (1987) 丁超 Supervisor
2 Wang, Yujiao (1981) 王玉姣 Supervisor 604 160 45 2,505 3,314
3 Ye, Xiang (1982) 葉翔 Sup Ch
Total 0 604 160 45 2,505 3,314

Directors

4 Fung, Anthony Che Wai 馮志偉 INED 185 185
5 Lin, Weidong (1982) 林偉棟 ED 1,273 400 71 4,523 6,267
6 Ling, Jianqun 凌建群 INED 185 185
7 Qiu, Jiwan 裘霽宛 Ch, CEO, Fdr 1,864 720 45 36,952 39,581
8 Wu, Yiliang 吳亦亮 ED 1,084 300 45 3,094 4,523
9 Wu, Zhiqiang (1981) 吳志強 NED
10 Xue, Mingyu 薛明宇 NED
11 Yu, Xi (1973) 余熹 NED
12 Zou, Zhongmei 鄒忠梅 INED 185 185
Total 555 4,221 1,420 161 44,569 50,926
Grand total 555 4,825 1,580 206 47,074 54,240

Main board pay history

Click on the year-end to see the pay details.

CNY'000

Year-end Fees Salary &
benefits
Bonus Retire Share-
based
Total
2024-12-31 555 4,221 1,420 161 44,569 50,926 Report
2023-12-31 0 4,228 1,420 154 67,296 73,098 Report
Total 555 8,449 2,840 315 111,865 124,024

Want to see more years here? volunteer to be a Webb-database editor and add the data from annual reports!


Copyright & disclaimer, Privacy policy

Back to top